Related Experiment Videos
Generalized exfoliative dermatitis from ethylenediamine
Archives of Dermatology
|April 1, 1976
Summary
Patients allergic to topical antibiotic creams may react to systemic medications containing ethylenediamine hydrochloride. This highlights the importance of checking for cross-reactivity when prescribing systemic drugs.
Area of Science:
- Pharmacology
- Dermatology
- Allergy and Immunology
Background:
- A patient with a known allergy to Mycolog, a topical antibiotic cream containing nystatin, neomycin sulfate, gramicidin, and triamcinolone acetonide, was administered aminophylline.
- The patient had a history of allergic reaction to the topical preparation.
Observation:
- Following administration of aminophylline, the patient developed a generalized exfoliative dermatitis.
- The observed skin reaction was severe and widespread.
Findings:
- The severe dermatological reaction was attributed to ethylenediamine hydrochloride.
- Ethylenediamine hydrochloride was identified as a common component in both the topical cream (Mycolog) and the systemic medication (aminophylline).
Implications:
- This case underscores the potential for systemic medications to trigger allergic reactions in patients with prior sensitivities to related topical agents.
- Clinicians must be aware of cross-reactivity risks, particularly with ingredients like ethylenediamine hydrochloride, when prescribing systemic drugs to patients with known topical allergies.